|
SEARCA-BIC Policy Brief Analyzes the Cost of Regulatory Delays for GM Crops
The first in a series of policy briefs released by the SEARCA Biotechnology Information Center (SEARCA BIC) is based on a study co-authored by Dr. Jose Benjamin Falck Zepeda, a Research Fellow at the International Food Policy and Research Institute (IFPRI) and Policy Team Leader at the Program for Biosafety Systems (PBS). The study sought to analyze the economic impact of regulatory delays for GM crops. By modeling several regulatory delay scenarios, results reveal that longer regulatory delays are associated with higher investment risk which could possibly discourage investments in the development of a GM crop. Findings of the analysis also emphasize the need for regulators, decision-makers, and developers to reduce time delays and increase the efficiency of coordinating decision points along the product development cycle -- for R&D, regulatory review, and compliance to optimize costs and time in delivering a product. The 2018 Policy Brief series is produced in partnership with the International Service for the Acquisition of Agri-biotech Applications (ISAAA), Coalition for Agriculture Modernization in the Philippines (CAMP), Department of Agriculture-Biotechnology Program Office (DA-BPO), Program for Biosafety Systems (PBS), and DA-Bureau of Agricultural Research (DA-BAR). For more details, read the full policy brief.
This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA) Subscribe to Crop Biotech Update Newsletter |
Regulatory approval times for 